Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

Alzheimer’s disease is the most common form of dementia, and epidemiological studies support that type 2 diabetes (T2D) is a major contributor. The relationship between both diseases and the fact that Alzheimer’s disease (AD) does not have a successful treatment support the study on antidiabetic dru...

Full description

Bibliographic Details
Main Authors: Maria Jose Carranza-Naval, Angel del Marco, Carmen Hierro-Bujalance, Pilar Alves-Martinez, Carmen Infante-Garcia, Maria Vargas-Soria, Marta Herrera, Belen Barba-Cordoba, Isabel Atienza-Navarro, Simon Lubian-Lopez, Monica Garcia-Alloza
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease
type 2 diabetes
liraglutide
neuronal loss
hemorrhage
inflammation
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.741923/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.741923/full

Similar Items